Clinical trial No longer in our active list Interventional Ages 18 to 100

Comparing two ventilation methods during laryngotracheal surgery

Official title: Comparison of Flow-Controlled Ventilation With EVONE Tritube and High Frequency Jet Ventilation in Patients Undergoing Laryngotracheal Surgery

Run by University Hospital, Geneva · NCT06063798 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing which breathing method, Flow Controlled Ventilation or High-Frequency Jet Ventilation, works better for protecting the lungs during laryngotracheal surgery in adults.

Quick facts

Study typeInterventional
Ages18 Years to 100 Years
SexAll
Enrollment50 (estimated)
SponsorUniversity Hospital, Geneva
Academic / other
Locations1 site (Geneva)
Trial IDNCT06063798 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adult patients scheduled for elective laryngotracheal surgery under general anesthesia.

Probably not a fit

Patients with severe heart or respiratory diseases, obesity, or those requiring tracheotomy will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the respiratory effects of two ventilation techniques, Flow Controlled Ventilation (FCV) and High-Frequency Jet Ventilation (HFJV), in patients undergoing laryngotracheal surgery under general anesthesia. The study is randomized and controlled, enrolling 50 adult patients who will be assigned to either the FCV or HFJV group. Measurements of lung function and respiratory mechanics will be taken before and after surgery to assess the effectiveness of each ventilation method. The goal is to determine which technique provides better lung protection and ventilation efficiency during the procedure.

Why it matters

Potential benefit: If successful, this study could lead to improved ventilation strategies that enhance lung protection during laryngotracheal surgeries.

How similar studies have gone: While the approach of using FCV is relatively novel, previous studies have indicated potential benefits of advanced ventilation techniques in similar surgical contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed Consent signed by the subject
* General anesthesia for laryngotracheal surgery
* Adult patients, female and male, over 18 years of age
* Elective surgery

Exclusion Criteria:

* Documented severe heart conditions (New York Heart Association Class 4, severe pulmonary hypertension)
* Documented severe respiratory disease (uncontrolled asthma, severe pulmonary fibrosis, chronic obstructive pulmonary disease GOLD 4)
* Documented severe Neurological diseases (Acute ischemic and hemorrhagic stroke within the preceding 3 months, uncontrolled seizures)
* Surgery that requires tracheotomy
* Obesity (Body Mass Index ≥ 30 kg/m2)
* Inability to follow the procedures of the study (mental condition or language barrier e.g. incomprehension of French language)
* Previous enrolment into the current study or other study that involves unknown medication in the past 12 months
* Allergy or contraindication to Propofol and/or Remifentanil and/or Rocuronium

Where it's running

  • Geneva University Hospitals
    Geneva, Switzerland
    Recruiting

Study contacts

  • Principal investigator: Gergely Albu, MD, PhD — University Hospital, Geneva
  • Study coordinator: Gergely Albu, MD, PhD
  • Email: gergely.albu@hcuge.ch
  • Phone: 0041795532052

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.